BIIB position history
The shares of Biogen (BIIB) that Krensavage Asset Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 103,202 shares, $29M, 9.2% of portfolio
- 2021 Q4: 103,053 shares, $25M, 8.6% of portfolio, Reduce −0.1%
- 2022 Q1: 111,353 shares, $23M, 8.1% of portfolio, Add +8.1%
- 2022 Q2: 117,248 shares, $24M, 7.9% of portfolio, Add +5.3%
- 2022 Q3: 184,648 shares, $49M, 15.7% of portfolio, Add +57.5%
- 2022 Q4: 177,004 shares, $49M, 15.1% of portfolio, Reduce −4.1%
- 2023 Q1: 177,126 shares, $49M, 15.0% of portfolio, Add +0.1%
- 2023 Q2: 176,826 shares, $50M, 16.0% of portfolio, Reduce −0.2%
- 2023 Q3: 160,480 shares, $41M, 15.2% of portfolio, Reduce −9.2%
- 2023 Q4: 160,480 shares, $42M, 14.7% of portfolio
- 2024 Q1: 134,068 shares, $29M, 12.8% of portfolio, Reduce −16.5%
- 2024 Q2: 123,785 shares, $29M, 13.2% of portfolio, Reduce −7.7%
- 2024 Q3: 113,502 shares, $22M, 12.3% of portfolio, Reduce −8.3%
- 2024 Q4: 222,425 shares, $33M, 19.7% of portfolio, Add +96.0%
- 2025 Q1: not held, Exit
- 2025 Q2: not held
- 2025 Q3: 10,000 shares, $1.4M, 0.60% of portfolio, New
- 2025 Q4: 10,000 shares, $1.8M, 0.62% of portfolio
- 2026 Q1: 20,000 shares, $3.7M, 1.4% of portfolio, Add +100.0%
- 2026 Q2: 20,000 shares, $4.3M, 1.6% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|